These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 1343855

  • 21. Vigabatrin in refractory epilepsy in adults and its application in children.
    Dam M.
    J Child Neurol; 1991; Suppl 2():S25-9. PubMed ID: 1940120
    [Abstract] [Full Text] [Related]

  • 22. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.
    Kälviäinen R, Aikiä M, Partanen J, Sivenius J, Mumford J, Saksa M, Riekkinen PJ.
    J Child Neurol; 1991; Suppl 2():S60-9. PubMed ID: 1940126
    [Abstract] [Full Text] [Related]

  • 23. [Therapeutic drug monitoring of vigabatrin].
    Bentué-Ferrer D, Tribut O, Verdier MC, le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010; 65(1):23-7. PubMed ID: 20205991
    [Abstract] [Full Text] [Related]

  • 24. Plasma concentrations of vigabatrin in epileptic patients.
    Sánchez-Alcaraz A, Quintana B, Rodriguez I, López E.
    J Clin Pharm Ther; 1996 Dec; 21(6):393-8. PubMed ID: 9201565
    [Abstract] [Full Text] [Related]

  • 25. Plasma GABA and seizure control with vigabatrin.
    Löscher W, Gram L, Stefan H.
    Lancet; 1993 Jan 09; 341(8837):117. PubMed ID: 8093385
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Simple high-performance liquid chromatographic method to monitor vigabatrin, and preliminary review of concentrations determined in epileptic patients.
    George S, Gill L, Braithwaite RA.
    Ann Clin Biochem; 2000 May 09; 37 ( Pt 3)():338-42. PubMed ID: 10817248
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of vigabatrin: implications of creatinine clearance.
    Haegele KD, Huebert ND, Ebel M, Tell GP, Schechter PJ.
    Clin Pharmacol Ther; 1988 Nov 09; 44(5):558-65. PubMed ID: 3180638
    [Abstract] [Full Text] [Related]

  • 38. Retinal and Systemic Toxicity of Vigabatrin Is Driven by the S-Enantiomer in the Long Evans Rat.
    Rasmussen AD, Truchot N, Dyssegaard A, Fant P.
    Toxicol Pathol; 2023 Apr 09; 51(3):126-134. PubMed ID: 37401471
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vigabatrin in medically resistant epilepsies - A preliminary experience with nine Saudi children.
    Al Jarallah A, Gascon GG.
    Ann Saudi Med; 1994 Mar 09; 14(2):165-6. PubMed ID: 17586879
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.